Clinical trial
Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study
NCT00870714 is registered in ClinicalTrials.gov with Kansas City Veteran Affairs Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study
- Lead sponsor
- Kansas City Veteran Affairs Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2004
- Completion date
- Not reported
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer